Sign In
Buy OABI
$2.33
+0.0100 (+0.431%)
At Close: Jun 23, 2026
OmniAb Q1 Earnings Call Highlights
04:08pm, Friday, 08'th May 2026
OmniAb NASDAQ: OABI reported first-quarter 2026 results that management characterized as a “very strong start to the year,” driven primarily by clinical progress across its partner portfolio and a
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates
11:26pm, Thursday, 07'th May 2026
OmniAb, Inc. (OABI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.17 per share a year ago.
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
04:05pm, Thursday, 07'th May 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program upda
OmniAb to Participate in Three Upcoming Investor Conferences
08:00am, Friday, 24'th Apr 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences over the coming weeks. H.C. Wainwri
OmniAb to Report First Quarter 2026 Financial Results on May 7
08:00am, Tuesday, 21'st Apr 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets
Matthew Foehr Sells 19,244 Shares of OmniAb (NASDAQ:OABI) Stock
04:54am, Thursday, 09'th Apr 2026
OmniAb, Inc. (NASDAQ: OABI - Get Free Report) CEO Matthew Foehr sold 19,244 shares of the business's stock in a transaction on Tuesday, April 7th. The shares were sold at an average price of $1.49, fo
OmniAb, Inc. (OABI) Q4 2025 Earnings Call Transcript
01:32am, Thursday, 05'th Mar 2026
OmniAb, Inc. (OABI) Q4 2025 Earnings Call Transcript
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates
06:55pm, Wednesday, 04'th Mar 2026
OmniAb, Inc. (OABI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.12 per share a year ago.
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
04:05pm, Wednesday, 04'th Mar 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner p
OmniAb (OABI) Projected to Post Earnings on Wednesday
02:46am, Monday, 02'nd Mar 2026
OmniAb (NASDAQ: OABI - Get Free Report) is expected to be releasing its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect the company to announce earnings of ($0.08) per
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
08:00am, Thursday, 19'th Feb 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the quarter and year ended December 31, 2025, after the close of the U.S. financial m
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript
07:39pm, Monday, 15'th Dec 2025
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra™ platform, the industry's first and only transgenic chicken engineered to e
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
04:05pm, Thursday, 04'th Dec 2025
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on Monday, December 15, 20
EMERYVILLE, Calif. & DENVER--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) and ArrowMark Partners (“ArrowMark”) today announced the signing of a license and services agreement for n
